Free Trial

Anupam Rama Analyst Performance

Analyst at JPMorgan Chase & Co.

Anupam Rama is a stock analyst at JPMorgan Chase & Co. focused in the medical sector, covering 40 publicly traded companies. Over the past year, Anupam Rama has issued 41 stock ratings, including buy, hold, and sell recommendations. While full access to Anupam Rama's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anupam Rama's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
101 Last 10 Years
Buy Recommendations
77.00% 77 Buy Ratings
Companies Covered
40 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy77.0%77 ratings
Hold20.0%20 ratings
Sell3.0%3 ratings

Out of 100 total stock ratings issued by Anupam Rama at JPMorgan Chase & Co., the majority (77.0%) have been Buy recommendations, followed by 20.0% Hold and 3.0% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
40 companies

Anupam Rama, an analyst at JPMorgan Chase & Co., currently covers 40 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
39 companies
97.5%
Energy
1 company
2.5%

Anupam Rama of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector, with additional focus on Energy companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
28 companies
70.0%
PHARMACEUTICAL PREPARATIONS
6 companies
15.0%
MED - DRUGS
3 companies
7.5%
MED - GENERIC DRG
1 company
2.5%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
2.5%
SOLAR
1 company
2.5%

Anupam Rama's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
9/16/2025Downgrade$2.74Neutral
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
9/3/2025Boost Price Target$52.20$70.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
9/3/2025Boost Price Target$25.93$74.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
8/14/2025Lower Price Target$6.27$13.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
8/14/2025Lower Price Target$9.71$17.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/14/2025Boost Price Target$5.24$29.00Overweight
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
8/14/2025Upgrade$8.62$15.00Neutral
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
8/7/2025Boost Price Target$10.79$30.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
8/7/2025Lower Price Target$19.72$53.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
8/4/2025Boost Price Target$24.26$37.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2025Boost Price Target$128.23$145.00Neutral
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
7/30/2025Upgrade$11.53$14.00Neutral
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/29/2025Upgrade$13.86$24.00Neutral
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
7/28/2025Boost Price Target$24.50$72.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/25/2025Reiterated Rating$12.89Underweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
7/24/2025Boost Price Target$26.91$80.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/22/2025Reiterated Rating$3.05$9.00Neutral
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/21/2025Lower Price Target$14.07$20.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/16/2025Boost Price Target$12.40$19.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
7/10/2025Boost Price Target$11.02$29.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/10/2025Lower Price Target$19.01$28.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/29/2025Boost Price Target$5.22$25.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
5/22/2025Boost Price Target$19.04$66.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
5/20/2025Lower Price Target$37.68$84.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/28/2025Lower Price Target$4.20$28.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
3/27/2025Boost Price Target$38.88$117.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
3/26/2025Boost Price Target$116.18$184.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
3/24/2025Boost Price Target$34.77$50.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/20/2025Boost Price Target$13.84$41.00Overweight
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
3/13/2025Boost Price Target$36.14$51.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/13/2025Lower Price Target$5.15$11.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/5/2025Boost Price Target$15.19$42.00Overweight
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/5/2025Lower Price Target$9.32$34.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/4/2025Boost Price Target$14.46$39.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
3/4/2025Boost Price Target$24.65$54.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
3/4/2025Lower Price Target$28.66$71.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
2/26/2025Boost Price Target$13.60$18.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/26/2025Boost Price Target$8.69$22.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
2/26/2025Boost Price Target$21.45$44.00Overweight
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
2/25/2025Initiated Coverage$10.82$30.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/6/2025Boost Price Target$12.72$21.00Overweight